VRTX logo

VRTX Operating Profit

Annual Operating Profit:

$4.39B+$87.50M(+2.03%)
December 31, 2024

Summary

  • As of today, VRTX annual operating income is $4.39 billion, with the most recent change of +$87.50 million (+2.03%) on December 31, 2024.
  • During the last 3 years, VRTX annual operating profit has risen by +$1.62 billion (+58.15%).
  • VRTX annual operating profit is now at all-time high.

Performance

VRTX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXincome statement metrics

Quarterly Operating Profit:

$1.24B+$63.30M(+5.38%)
September 30, 2025

Summary

  • As of today, VRTX quarterly operating income is $1.24 billion, with the most recent change of +$63.30 million (+5.38%) on September 30, 2025.
  • Over the past year, VRTX quarterly operating profit has increased by +$119.10 million (+10.64%).
  • VRTX quarterly operating profit is now at all-time high.

Performance

VRTX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXincome statement metrics

TTM Operating Profit:

$4.49B+$119.10M(+2.73%)
September 30, 2025

Summary

  • As of today, VRTX TTM operating income is $4.49 billion, with the most recent change of +$119.10 million (+2.73%) on September 30, 2025.
  • Over the past year, VRTX TTM operating profit has increased by +$4.80 billion (+1558.51%).
  • VRTX TTM operating profit is now at all-time high.

Performance

VRTX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

VRTX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+2.0%+10.6%+1558.5%
3Y3 Years+58.1%+17.0%+13.6%
5Y5 Years+265.6%+81.8%+68.7%

VRTX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+58.1%at high+135.1%at high+1248.2%
5Y5-Yearat high+265.6%at high+135.1%at high+1248.2%
All-TimeAll-Timeat high+732.8%at high+135.1%at high+746.3%

VRTX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.24B(+5.4%)
$4.49B(+2.7%)
Jun 2025
-
$1.18B(+19.1%)
$4.37B(+1422.7%)
Mar 2025
-
$987.20M(-9.2%)
-$330.40M(-81.9%)
Dec 2024
$4.39B(+2.0%)
$1.09B(-2.8%)
-$181.60M(+41.0%)
Sep 2024
-
$1.12B(+131.8%)
-$307.80M(+21.3%)
Jun 2024
-
-$3.53B(-410.3%)
-$391.00M(-109.4%)
Mar 2024
-
$1.14B(+18.1%)
$4.15B(+10.1%)
Dec 2023
$4.31B(-1.3%)
$961.60M(-7.2%)
$3.77B(-1.2%)
Sep 2023
-
$1.04B(+1.9%)
$3.82B(-0.6%)
Jun 2023
-
$1.02B(+34.8%)
$3.84B(+0.1%)
Mar 2023
-
$755.10M(-25.2%)
$3.84B(-6.3%)
Dec 2022
$4.37B(+57.1%)
$1.01B(-4.7%)
$4.09B(+3.5%)
Sep 2022
-
$1.06B(+4.6%)
$3.95B(-0.1%)
Jun 2022
-
$1.01B(-0.1%)
$3.96B(+35.2%)
Mar 2022
-
$1.01B(+16.6%)
$2.92B(+4.0%)
Dec 2021
$2.78B(-3.2%)
$869.16M(-18.1%)
$2.81B(+4.1%)
Sep 2021
-
$1.06B(+5755.0%)
$2.70B(+16.4%)
Jun 2021
-
-$18.76M(-102.1%)
$2.32B(-24.2%)
Mar 2021
-
$900.44M(+18.8%)
$3.06B(+6.5%)
Dec 2020
$2.87B(+138.7%)
$758.04M(+11.3%)
$2.87B(+8.0%)
Sep 2020
-
$681.29M(-5.5%)
$2.66B(+28.4%)
Jun 2020
-
$720.87M(+1.1%)
$2.07B(+28.5%)
Mar 2020
-
$712.90M(+30.6%)
$1.61B(+37.9%)
Dec 2019
$1.20B(+81.0%)
$545.80M(+493.3%)
$1.17B(+51.1%)
Sep 2019
-
$91.99M(-64.9%)
$774.22M(-12.6%)
Jun 2019
-
$261.72M(-3.1%)
$885.99M(+10.8%)
Mar 2019
-
$269.97M(+79.3%)
$799.88M(+21.4%)
Dec 2018
$663.97M(+69.0%)
$150.54M(-26.1%)
$658.73M(+3.8%)
Sep 2018
-
$203.75M(+16.0%)
$634.32M(+73.6%)
Jun 2018
-
$175.62M(+36.3%)
$365.30M(+49.7%)
Mar 2018
-
$128.82M(+2.1%)
$243.94M(-38.4%)
Dec 2017
$392.83M(+3408.0%)
$126.12M(+293.2%)
$395.96M(+27.9%)
Sep 2017
-
-$65.27M(-220.3%)
$309.70M(-13.1%)
Jun 2017
-
$54.26M(-80.7%)
$356.24M(+16.5%)
Mar 2017
-
$280.84M(+604.5%)
$305.68M(+2629.8%)
Dec 2016
$11.20M(+102.4%)
$39.86M(+313.0%)
$11.20M(+113.6%)
Sep 2016
-
-$18.72M(-606.5%)
-$82.63M(+37.5%)
Jun 2016
-
$3.70M(+127.1%)
-$132.11M(+56.7%)
Mar 2016
-
-$13.64M(+74.7%)
-$304.84M(+34.6%)
Dec 2015
-$464.67M(+27.6%)
-$53.96M(+20.9%)
-$466.46M(+17.0%)
Sep 2015
-
-$68.20M(+59.7%)
-$561.95M(+5.6%)
Jun 2015
-
-$169.04M(+3.5%)
-$595.11M(+2.0%)
Mar 2015
-
-$175.26M(-17.3%)
-$607.18M(+5.4%)
Dec 2014
-$641.49M(-309.7%)
-$149.46M(-47.5%)
-$642.13M(-31.4%)
Sep 2014
-
-$101.36M(+44.0%)
-$488.57M(+4.1%)
Jun 2014
-
-$181.10M(+13.8%)
-$509.23M(-32.5%)
Mar 2014
-
-$210.20M(-5231.8%)
-$384.28M(-92.7%)
Dec 2013
-$156.59M(-422.4%)
$4.10M(+103.4%)
-$199.43M(+29.0%)
Sep 2013
-
-$122.02M(-117.3%)
-$280.81M(-76.4%)
Jun 2013
-
-$56.16M(-121.5%)
-$159.16M(-40.6%)
Mar 2013
-
-$25.35M(+67.2%)
-$113.18M(-2810.3%)
Dec 2012
$48.57M(-78.1%)
-$77.28M(>-9900.0%)
$4.18M(-98.6%)
Sep 2012
-
-$375.00K(+96.3%)
$306.35M(-51.2%)
Jun 2012
-
-$10.18M(-111.1%)
$627.82M(+32.8%)
Mar 2012
-
$92.01M(-59.1%)
$472.84M(+113.3%)
Dec 2011
$221.69M(+131.9%)
$224.89M(-30.0%)
$221.69M(+228.8%)
Sep 2011
-
$321.09M(+294.4%)
-$172.09M(+75.1%)
Jun 2011
-
-$165.15M(-3.8%)
-$691.90M(+0.3%)
Mar 2011
-
-$159.14M(+5.8%)
-$694.21M(+0.1%)
Dec 2010
-$694.58M(-17.2%)
-$168.89M(+15.0%)
-$694.58M(-4.7%)
Sep 2010
-
-$198.72M(-18.7%)
-$663.25M(-8.4%)
Jun 2010
-
-$167.46M(-5.0%)
-$611.98M(-1.9%)
Mar 2010
-
-$159.50M(-15.9%)
-$600.58M(-1.3%)
Dec 2009
-$592.78M(-29.3%)
-$137.56M(+6.7%)
-$592.78M(+0.4%)
Sep 2009
-
-$147.46M(+5.5%)
-$595.44M(-3.1%)
Jun 2009
-
-$156.06M(-2.9%)
-$577.72M(-12.8%)
Mar 2009
-
-$151.70M(-8.2%)
-$511.98M(-11.7%)
Dec 2008
-$458.38M(-11.1%)
-$140.22M(-8.1%)
-$458.38M(-11.9%)
Sep 2008
-
-$129.74M(-43.7%)
-$409.63M(-4.3%)
Jun 2008
-
-$90.31M(+7.9%)
-$392.80M(+8.1%)
Mar 2008
-
-$98.11M(-7.3%)
-$427.20M(-3.5%)
DateAnnualQuarterlyTTM
Dec 2007
-$412.67M(-83.1%)
-$91.47M(+19.0%)
-$412.67M(-16.2%)
Sep 2007
-
-$112.91M(+9.5%)
-$355.11M(-17.2%)
Jun 2007
-
-$124.71M(-49.2%)
-$302.91M(-17.9%)
Mar 2007
-
-$83.57M(-146.5%)
-$256.97M(-14.0%)
Dec 2006
-$225.39M(-59.0%)
-$33.91M(+44.2%)
-$225.39M(-6.6%)
Sep 2006
-
-$60.71M(+22.9%)
-$211.48M(-10.3%)
Jun 2006
-
-$78.78M(-51.5%)
-$191.68M(-25.1%)
Mar 2006
-
-$51.99M(-160.0%)
-$153.24M(-8.1%)
Dec 2005
-$141.74M(-3.3%)
-$20.00M(+51.1%)
-$141.74M(+12.6%)
Sep 2005
-
-$40.92M(-1.4%)
-$162.18M(-3.4%)
Jun 2005
-
-$40.34M(+0.4%)
-$156.85M(+0.0%)
Mar 2005
-
-$40.49M(-0.1%)
-$156.91M(-3.8%)
Dec 2004
-$137.23M(+20.5%)
-$40.44M(-13.6%)
-$151.15M(-1.4%)
Sep 2004
-
-$35.59M(+11.9%)
-$149.12M(+4.9%)
Jun 2004
-
-$40.40M(-16.3%)
-$156.84M(+2.8%)
Mar 2004
-
-$34.73M(+9.6%)
-$161.32M(+8.7%)
Dec 2003
-$172.70M(-16.7%)
-$38.41M(+11.3%)
-$176.62M(-2.8%)
Sep 2003
-
-$43.31M(+3.5%)
-$171.87M(-4.5%)
Jun 2003
-
-$44.88M(+10.3%)
-$164.42M(-14.5%)
Mar 2003
-
-$50.03M(-48.6%)
-$143.57M(-20.0%)
Dec 2002
-$147.96M(-28.5%)
-$33.66M(+6.1%)
-$119.60M(-14.3%)
Sep 2002
-
-$35.85M(-49.2%)
-$104.69M(-17.3%)
Jun 2002
-
-$24.03M(+7.8%)
-$89.24M(-8.0%)
Mar 2002
-
-$26.06M(-39.0%)
-$82.66M(-14.8%)
Dec 2001
-$115.10M(-207.4%)
-$18.75M(+8.1%)
-$71.99M(-6.4%)
Sep 2001
-
-$20.40M(-16.9%)
-$67.65M(-8.4%)
Jun 2001
-
-$17.45M(-13.3%)
-$62.42M(-75.7%)
Mar 2001
-
-$15.39M(-6.9%)
-$35.52M(+8.2%)
Dec 2000
-$37.44M(+26.0%)
-$14.40M(+5.1%)
-$38.68M(-54.6%)
Sep 2000
-
-$15.17M(-260.5%)
-$25.03M(+4.5%)
Jun 2000
-
$9.45M(+150.9%)
-$26.19M(+46.4%)
Mar 2000
-
-$18.56M(-2388.1%)
-$48.82M(+3.7%)
Dec 1999
-$50.60M(-5.9%)
-$746.00K(+95.4%)
-$50.68M(+23.2%)
Sep 1999
-
-$16.34M(-24.0%)
-$65.99M(-18.8%)
Jun 1999
-
-$13.18M(+35.4%)
-$55.53M(+0.7%)
Mar 1999
-
-$20.41M(-27.1%)
-$55.90M(-17.1%)
Dec 1998
-$47.80M(-149.0%)
-$16.06M(-173.1%)
-$47.75M(-25.0%)
Sep 1998
-
-$5.88M(+56.6%)
-$38.19M(-0.5%)
Jun 1998
-
-$13.55M(-10.5%)
-$38.01M(-48.1%)
Mar 1998
-
-$12.26M(-88.6%)
-$25.66M(-35.1%)
Dec 1997
-$19.20M(+51.4%)
-$6.50M(-14.0%)
-$19.00M(+31.4%)
Sep 1997
-
-$5.70M(-375.0%)
-$27.70M(+5.8%)
Jun 1997
-
-$1.20M(+78.6%)
-$29.40M(+19.5%)
Mar 1997
-
-$5.60M(+63.2%)
-$36.50M(+7.6%)
Dec 1996
-$39.50M(-49.1%)
-$15.20M(-105.4%)
-$39.50M(-48.5%)
Sep 1996
-
-$7.40M(+10.8%)
-$26.60M(+2.2%)
Jun 1996
-
-$8.30M(+3.5%)
-$27.20M(+6.8%)
Mar 1996
-
-$8.60M(-273.9%)
-$29.20M(-10.2%)
Dec 1995
-$26.50M(-28.0%)
-$2.30M(+71.3%)
-$26.50M(+18.7%)
Sep 1995
-
-$8.00M(+22.3%)
-$32.60M(-14.8%)
Jun 1995
-
-$10.30M(-74.6%)
-$28.40M(-20.9%)
Mar 1995
-
-$5.90M(+29.8%)
-$23.50M(-13.0%)
Dec 1994
-$20.70M(-1825.0%)
-$8.40M(-121.1%)
-$20.80M(-447.4%)
Sep 1994
-
-$3.80M(+29.6%)
-$3.80M(-31.0%)
Jun 1994
-
-$5.40M(-68.8%)
-$2.90M(-293.3%)
Mar 1994
-
-$3.20M(-137.2%)
$1.50M(+25.0%)
Dec 1993
$1.20M(+112.0%)
$8.60M(+396.6%)
$1.20M(+111.7%)
Sep 1993
-
-$2.90M(-190.0%)
-$10.30M(-3.0%)
Jun 1993
-
-$1.00M(+71.4%)
-$10.00M(+11.5%)
Mar 1993
-
-$3.50M(-20.7%)
-$11.30M(-14.1%)
Dec 1992
-$10.00M(-78.6%)
-$2.90M(-11.5%)
-$9.90M(-13.8%)
Sep 1992
-
-$2.60M(-13.0%)
-$8.70M(-16.0%)
Jun 1992
-
-$2.30M(-9.5%)
-$7.50M(-15.4%)
Mar 1992
-
-$2.10M(-23.5%)
-$6.50M(-80.6%)
Dec 1991
-$5.60M(-36.6%)
-$1.70M(-21.4%)
-$3.60M(+53.2%)
Sep 1991
-
-$1.40M(-7.7%)
-$7.70M(-35.1%)
Jun 1991
-
-$1.30M(-262.5%)
-$5.70M(-50.0%)
Mar 1991
-
$800.00K(+113.8%)
-$3.80M(+7.3%)
Dec 1990
-$4.10M
-$5.80M(-1066.7%)
-$4.10M(-341.2%)
Sep 1990
-
$600.00K(0.0%)
$1.70M(+54.5%)
Jun 1990
-
$600.00K(+20.0%)
$1.10M(+120.0%)
Mar 1990
-
$500.00K
$500.00K

FAQ

  • What is Vertex Pharmaceuticals Incorporated annual operating income?
  • What is the all-time high annual operating profit for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated annual operating profit year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated quarterly operating income?
  • What is the all-time high quarterly operating profit for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated TTM operating income?
  • What is the all-time high TTM operating profit for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated TTM operating profit year-on-year change?

What is Vertex Pharmaceuticals Incorporated annual operating income?

The current annual operating profit of VRTX is $4.39B

What is the all-time high annual operating profit for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high annual operating income is $4.39B

What is Vertex Pharmaceuticals Incorporated annual operating profit year-on-year change?

Over the past year, VRTX annual operating income has changed by +$87.50M (+2.03%)

What is Vertex Pharmaceuticals Incorporated quarterly operating income?

The current quarterly operating profit of VRTX is $1.24B

What is the all-time high quarterly operating profit for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high quarterly operating income is $1.24B

What is Vertex Pharmaceuticals Incorporated quarterly operating profit year-on-year change?

Over the past year, VRTX quarterly operating income has changed by +$119.10M (+10.64%)

What is Vertex Pharmaceuticals Incorporated TTM operating income?

The current TTM operating profit of VRTX is $4.49B

What is the all-time high TTM operating profit for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high TTM operating income is $4.49B

What is Vertex Pharmaceuticals Incorporated TTM operating profit year-on-year change?

Over the past year, VRTX TTM operating income has changed by +$4.80B (+1558.51%)
On this page